U.S Physical Therapy Long Term Debt 2012-2025 | USPH

U.S Physical Therapy long term debt from 2012 to 2025. Long term debt can be defined as the sum of all long term debt fields.
U.S Physical Therapy Annual Long Term Debt
(Millions of US $)
2024 $143
2023 $139
2022 $176
2021 $118
2020 $17
2019 $50
2018 $38
2017 $57
2016 $51
2015 $48
2014 $35
2013 $41
2012 $18
2011 $24
U.S Physical Therapy Quarterly Long Term Debt
(Millions of US $)
2025-09-30 $151
2025-06-30 $152
2025-03-31 $157
2024-12-31 $143
2024-09-30 $133
2024-06-30 $136
2024-03-31 $137
2023-12-31 $139
2023-09-30 $141
2023-06-30 $143
2023-03-31 $183
2022-12-31 $176
2022-09-30 $147
2022-06-30 $149
2022-03-31 $122
2021-12-31 $118
2021-09-30 $35
2021-06-30 $39
2021-03-31 $17
2020-12-31 $17
2020-09-30 $8
2020-06-30 $34
2020-03-31 $119
2019-12-31 $50
2019-09-30 $55
2019-06-30 $66
2019-03-31 $30
2018-12-31 $38
2018-09-30 $55
2018-06-30 $57
2018-03-31 $43
2017-12-31 $57
2017-09-30 $60
2017-06-30 $73
2017-03-31 $63
2016-12-31 $51
2016-09-30 $41
2016-06-30 $47
2016-03-31 $57
2015-12-31 $48
2015-09-30 $48
2015-06-30 $42
2015-03-31 $42
2014-12-31 $35
2014-09-30 $47
2014-06-30 $45
2014-03-31 $46
2013-12-31 $41
2013-09-30 $15
2013-06-30 $16
2013-03-31 $21
2012-12-31 $18
2012-09-30 $16
2012-06-30 $20
2012-03-31 $25
2011-12-31 $24
2011-09-30 $27
2011-06-30 $16
2011-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.308B $0.671B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $21.079B 19.62
Elanco Animal Health (ELAN) United States $12.188B 25.55
Encompass Health (EHC) United States $10.112B 19.44
DaVita (DVA) United States $7.395B 10.80
Chemed (CHE) United States $6.401B 22.48
Option Care Health (OPCH) United States $5.719B 24.34
RadNet (RDNT) United States $5.477B 186.82
LifeStance Health (LFST) United States $2.820B 0.00
Addus HomeCare (ADUS) United States $1.987B 20.52
Aveanna Healthcare Holdings (AVAH) United States $1.926B 24.26
Astrana Health (ASTH) United States $1.517B 141.84
Pennant (PNTG) United States $1.008B 33.51
Daxor (DXR) United States $0.066B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.050B 0.00
Psychemedics (PMD) United States $0.000B 0.00